Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD981 in Obesity Hypoventilation Syndrome
NCT05448443Phase 2Completed
- Sponsor
- Istituto Auxologico Italiano
- Start
- Jun 2022
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity hypoventilation syndrome (OHS) comparing AD981 with Placebo (2 arms). Primary endpoint: Nocturnal transcutaneous CO2 pressure at 14 days. Started Jun 2022; status: completed.
02
Drugs
AD981
03
Conditions
obesity hypoventilation syndrome (OHS)
Beyond the preview
Go deeper on NCT05448443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05448443.